Menu
Sign In Search Podcasts Charts Entities Add Podcast API Pricing
Podcast Image

Breaking Beta | The Science of Climbing

Can We Minimize Tendon Injury and Return More Quickly to Climbing?

12 Jan 2022

Description

In this episode, Kris and Paul discuss another study examining a type of injury commonly seen in climbers: Minimizing Injury and Maximizing Return to Play: Lessons from Engineered Ligaments authored by Keith Baar, published in Sports Medicine (Springer Nature) in 2017. They’ll attempt to determine whether or not there’s much we can do to help prevent tendon injuries and speed up recovery time when they do occur. Tune in to find out if that friend who swears their collagen supplements are the key to their fingers of steel is actually on to something, or totally full of it.   *Additional studies/resources mentioned in this episode: Stress Relaxation and Targeted Nutrition to Treat Patellar Tendinopathy  authored by Keith Baar, published in the International Journal of Sport Nutrition and Exercise Metabolism, 2018.   New episodes drop on Wednesdays. Make sure you’re subscribed, leave us a review, and share! And tell all of your friends who keep telling you that you should rest every single one of your tendon tweaks until they're gone, that you have the perfect podcast for them.   Breaking Beta is brought to you by Power Company Climbing and Crux Conditioning, and is a proud member of the Plug Tone Audio Collective. Find full episode transcripts, citations, and more at our website. Follow Kris and Breaking Beta on Instagram  Follow Paul and Crux Conditioning on Instagram  If you have questions, comments, or want to suggest a paper we should cover, find us at our Community + Knowledge Hub. Our music is from legendary South Dakota band Rifflord.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

No transcription available yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.